These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11140732)

  • 1. Antimitotic and cell growth inhibitory properties of combretastatin A-4-like ethers.
    Lawrence NJ; Rennison D; Woo M; McGown AT; Hadfield JA
    Bioorg Med Chem Lett; 2001 Jan; 11(1):51-4. PubMed ID: 11140732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel sulfonate analogues of combretastatin A-4: potent antimitotic agents.
    Gwaltney SL; Imade HM; Barr KJ; Li Q; Gehrke L; Credo RB; Warner RB; Lee JY; Kovar P; Wang J; Nukkala MA; Zielinski NA; Frost D; Ng SC; Sham HL
    Bioorg Med Chem Lett; 2001 Apr; 11(7):871-4. PubMed ID: 11294380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4,5-Diaryl-3-aminopyrazole derivatives as analogs of Combretastatin A-4: synthesis and biological evaluation.
    Liu T; Cui R; Chen J; Zhang J; He Q; Yang B; Hu Y
    Arch Pharm (Weinheim); 2011 May; 344(5):279-86. PubMed ID: 21290430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medicinal chemistry of combretastatin A4: present and future directions.
    Tron GC; Pirali T; Sorba G; Pagliai F; Busacca S; Genazzani AA
    J Med Chem; 2006 Jun; 49(11):3033-44. PubMed ID: 16722619
    [No Abstract]   [Full Text] [Related]  

  • 5. Antineoplastic agents. 291. Isolation and synthesis of combretastatins A-4, A-5, and A-6(1a).
    Pettit GR; Singh SB; Boyd MR; Hamel E; Pettit RK; Schmidt JM; Hogan F
    J Med Chem; 1995 May; 38(10):1666-72. PubMed ID: 7752190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combretastatin A-4 analogues as antimitotic antitumor agents.
    Nam NH
    Curr Med Chem; 2003 Sep; 10(17):1697-722. PubMed ID: 12871118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of silicon-containing tubulin polymerization inhibitors: replacement of the ethylene moiety of combretastatin A-4 with a silicon linker.
    Nakamura M; Kajita D; Matsumoto Y; Hashimoto Y
    Bioorg Med Chem; 2013 Dec; 21(23):7381-91. PubMed ID: 24139940
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of novel 3,4-diaryl-1,2,5-selenadiazol analogues of combretastatin A-4.
    Guan Q; Yang F; Guo D; Xu J; Jiang M; Liu C; Bao K; Wu Y; Zhang W
    Eur J Med Chem; 2014 Nov; 87():1-9. PubMed ID: 25233100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of cyclic derivatives of combretastatin A-4 containing group 14 elements.
    Blasco V; Murga J; Falomir E; Carda M; Royo S; Cuñat AC; Sanz-Cervera JF; Marco JA
    Org Biomol Chem; 2018 Aug; 16(32):5859-5870. PubMed ID: 30070286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of double bond substituted combretastatins.
    Hadfield JA; Gaukroger K; Hirst N; Weston AP; Lawrence NJ; McGown AT
    Eur J Med Chem; 2005 Jun; 40(6):529-41. PubMed ID: 15922837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interaction with tubulin of a series of stilbenes based on combretastatin A-4.
    Woods JA; Hadfield JA; Pettit GR; Fox BW; McGown AT
    Br J Cancer; 1995 Apr; 71(4):705-11. PubMed ID: 7710932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, biochemical, and biological evaluation of nitrogen-containing trifluoro structural modifications of combretastatin A-4.
    Hall JJ; Sriram M; Strecker TE; Tidmore JK; Jelinek CJ; Kumar GD; Hadimani MB; Pettit GR; Chaplin DJ; Trawick ML; Pinney KG
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5146-9. PubMed ID: 18710804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and antitumor activity of benzils related to combretastatin A-4.
    Mousset C; Giraud A; Provot O; Hamze A; Bignon J; Liu JM; Thoret S; Dubois J; Brion JD; Alami M
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3266-71. PubMed ID: 18477509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, and biological evaluation of novel combretastatin A-4 thio derivatives as microtubule targeting agents.
    Stefański T; Mikstacka R; Kurczab R; Dutkiewicz Z; Kucińska M; Murias M; Zielińska-Przyjemska M; Cichocki M; Teubert A; Kaczmarek M; Hogendorf A; Sobiak S
    Eur J Med Chem; 2018 Jan; 144():797-816. PubMed ID: 29291446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and anticancer properties of 5-arylbenzoxepins as conformationally restricted isocombretastatin A-4 analogs.
    Rasolofonjatovo E; Provot O; Hamze A; Rodrigo J; Bignon J; Wdzieczak-Bakala J; Lenoir C; Desravines D; Dubois J; Brion JD; Alami M
    Eur J Med Chem; 2013 Apr; 62():28-39. PubMed ID: 23353744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lead identification of conformationally restricted β-lactam type combretastatin analogues: synthesis, antiproliferative activity and tubulin targeting effects.
    Carr M; Greene LM; Knox AJ; Lloyd DG; Zisterer DM; Meegan MJ
    Eur J Med Chem; 2010 Dec; 45(12):5752-66. PubMed ID: 20933304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation, and structure-activity relationships of tri- and tetrasubstituted olefins related to isocombretastatin A-4 as new tubulin inhibitors.
    Aziz J; Brachet E; Hamze A; Peyrat JF; Bernadat G; Morvan E; Bignon J; Wdzieczak-Bakala J; Desravines D; Dubois J; Tueni M; Yassine A; Brion JD; Alami M
    Org Biomol Chem; 2013 Jan; 11(3):430-42. PubMed ID: 23047722
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimitotic activity of diaryl compounds with structural features resembling combretastatin A-4.
    Aleksandrzak K; McGown AT; Hadfield JA
    Anticancer Drugs; 1998 Jul; 9(6):545-50. PubMed ID: 9877243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and structure-activity relationships of 3-aminobenzophenones as antimitotic agents.
    Liou JP; Chang JY; Chang CW; Chang CY; Mahindroo N; Kuo FM; Hsieh HP
    J Med Chem; 2004 May; 47(11):2897-905. PubMed ID: 15139768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of analogues of (Z)-1-(4-methoxyphenyl)-2-(3,4,5-trimethoxyphenyl)ethene as potential cytotoxic and antimitotic agents.
    Cushman M; Nagarathnam D; Gopal D; He HM; Lin CM; Hamel E
    J Med Chem; 1992 Jun; 35(12):2293-306. PubMed ID: 1613753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.